SCHEMBL29689147

SCHEMBL29689147

Cc1cc(Nc2ccccn2)c(N)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 5/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
GFER P55789 1/20 0.53
KDR P35968 3/20 0.45
UHRF1 Q96T88 1/20 0.42
GRM5 P41594 1/20 0.41
CCNK O75909 1/20 0.39
CCNA2 P20248 1/20 0.39
CDK2 P24941 1/20 0.39
CCND3 P30281 1/20 0.39
CDK9 P50750 1/20 0.39
CDK6 Q00534 1/20 0.39
ALDH1A1 P00352 2/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
USP2 O75604 1/20 0.39
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16035800 1.00 MAPK10 (0.53) MAPK10MEN1KMT2AGFERKDR
SCHEMBL28688015 0.88 MAPK10 (0.53) MAPK10MEN1KMT2AGFERKDR
SCHEMBL6832802 0.79 MEN1 (0.55) MAPK10MEN1KMT2AGFERKDR
SCHEMBL16036492 0.79 UHRF1 (0.43) MAPK10MEN1KMT2AKDRUHRF1
SCHEMBL29689666 0.79 UHRF1 (0.43) MAPK10MEN1KMT2AKDRUHRF1
SCHEMBL12901052 0.78 MEN1 (0.49) MAPK10MEN1KMT2AGFERKDR
SCHEMBL6836695 0.76 MAPK10 (0.55) MAPK10MEN1KMT2AGFERKDR
SCHEMBL16089597 0.76 MAPK10 (0.58) MAPK10MEN1KMT2AGFERKDR
SCHEMBL18199830 0.74 MEN1 (0.67) MAPK10MEN1KMT2AGFERKDR
SCHEMBL4943709 0.74 MEN1 (0.73) MAPK10MEN1KMT2AGFERKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12247027-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2025-03-11 US disclosed
US-20240116930-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-04-11 US disclosed
US-11820770-B2 P2X7 modulators JANSSEN PHARMACEUTICA NV (BE) 2023-11-21 US disclosed
US-20220213095-A1 P2X7 MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12247027-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 MAPK10 1692/4885MEN1 3516/4885KMT2A 4346/4885
US-11820770-B2 P2X7 modulators P2RX2, P2RX7, P2RY2 MAPK10 1692/4885MEN1 3516/4885KMT2A 4346/4885
US-20220213095-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 MAPK10 1692/4885MEN1 3516/4885KMT2A 4346/4885
US-20240116930-A1 P2X7 MODULATORS P2RX2, P2RX7, P2RY2 MAPK10 1692/4885MEN1 3516/4885KMT2A 4346/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.